Zypsilan 40 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 40 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Zypsilan 60 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 60 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Zypsilan 80 mg Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 80 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

EMESTO SILVER Slovakien - slovakiska - myHealthbox

emesto silver

bayer ag - stabilná suspenzia - penflufen 100 g/l; prothioconazole 18 g

ALTEANA Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

alteana

imuna pharm, a.s., slovensko - tetanový toxoid - 59 - immunopraeparata

CARDIORAL 75 mg mäkké kapsuly Slovakien - slovakiska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

cardioral 75 mg mäkké kapsuly

ibsa slovakia s.r.o., slovensko - kyselina acetylsalicylová - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Supemtek Europeiska unionen - slovakiska - EMA (European Medicines Agency)

supemtek

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - chrípka, človek - vakcíny - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

INPUT Slovakien - slovakiska - myHealthbox

input

bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l

Vaxneuvance Europeiska unionen - slovakiska - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokokové infekcie - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pozri časti 4. 4 a 5. 1 pre informácie o ochrane proti špecifickým pneumokokovým sérotypom. the use of vaxneuvance should be in accordance with official recommendations.

INPUT Slovakien - slovakiska - myHealthbox

input

bayer ag - emulzný koncentrát - prothioconazole 160 g/l; spiroxamine 300 g/l